There are a few different types of common procedures, and your specific situation will determine which is right for you, says Dana Lukin, MD, a gastroenterologist at Weill Cornell Medicine and NewYork ...

Severe flare-ups are one of the greatest challenges of living with ulcerative colitis (UC). One option to try alongside your usual treatments is a low-residue diet. Its meant to reduce the amount of ...

AbbVie is ending development of an IL-1 asset as a monotherapy in ulcerative colitis (UC) after a phase 2 study revealed insufficient efficacy results. “An interim analysis was recently completed on ...

(a) Atrophic/withering crypts (red arrow) and lamina propria vascular congestion. Notice that the cellularity of the lamina propria is not significantly increased. (b) Vascular congestion and ...

Whether it's a dull ache, sharp cramp or persistent discomfort, most of us have experienced some degree of stomach pain throughout our lives. While something as mild as indigestion, gas, bloating or ...

Colitis and ulcerative colitis (UC) can look very similar because they share symptoms like abdominal pain, diarrhea, and bloody stool, and they both involve inflammation of the colon (the large ...

Chronic lymphocytic leukemia (CLL) remains an incurable disease, except in rare cases treated with allogeneic stem-cell transplantation or favorable-risk CLL treated with chemoimmunotherapy. Treatment ...

"Transitioning patients in my practice is super-important to ensure seamless pediatric to adult care" for ulcerative colitis, says Jordan Axelrad, MD, associate professor of medicine at the NYU ...

There is no specific diet for ischemic colitis. However, a healthcare professional may suggest a liquid diet or no food during certain stages of treatment. Ischemic colitis is a condition in which not ...

EEN is primarily used for Crohn's disease, but its effectiveness in ulcerative colitis is unclear, necessitating further research. A systematic review analyzed 70 studies, finding no significant ...

Whether fixed-duration acalabrutinib–venetoclax (with or without obinutuzumab) would result in better progression-free survival than chemoimmunotherapy in patients with untreated chronic lymphocytic ...

Chronic lymphocytic leukemia (CLL) and prolymphocytic leukemia (PLL) are types of blood cancer. They develop in types of white blood cells called B cells or T cells, or the precursors to these cells.